pure peptide labs tirzepatide GLP-2 TZ – True Lab Peptides Premium Tirzepatide Peptide | Dual
Description
A post hoc analysis of the SURMOUNT-1 trial, published in Diabetes, Obesity and Metabolism in 2025, found that 18% of tirzepatide-treated participants had lost less than 5% of their body weight at the 12-week mark

Your doctor may refer you to a registered dietitian, exercise specialist, or behavioral health professional as part of a comprehensive treatment plan, consistent with American Gastroenterological Association and American Academy of Pediatrics guidelines

Semaglutide (Ozempic, Novo Nordisk, Bagsvrd, Denmark) and tirzepatide (Mounjaro, Eli Lilly and Company, Indianapolis, IN, USA) were used

Both medications are effective, but tirzepatide consistently outperforms semaglutide in clinical trials
